Exolaunch Signs Agreement for First Starship Starfall Reentry Mission

German launch integrator Exolaunch has signed an agreement to support customer payloads on a SpaceX Starfall reentry mission, marking the company’s first commitment to the Starship vehicle and its first foray into Earth-return services.

What Happened

Under the new agreement, Exolaunch will act as the payload integrator for a Starfall mission scheduled to launch No Earlier Than (NET) 2029. The company will be responsible for filling the vehicle’s 1,000 kg payload capacity with customer experiments spanning biotech, pharmaceutical, and in-space manufacturing applications.

Exolaunch will manage the technical, logistical, operational, and regulatory requirements for these customers under the reentry program. According to Chief Marketing Officer Jeanne Allarie, the company is also considering building or acquiring new hardware to support these payloads inside the Starship vehicle.

Why It Matters

This deal represents a significant expansion of the commercial reentry market, which is increasingly relying on Starship’s capacity to return experiments from microgravity. Exolaunch intends to leverage relationships established through SpaceX’s Transporter rideshare program to drive customers to this new offering.

The company’s pipeline may receive a further boost from its pending acquisition by global investment firm EQT, expected to close in Q4 2026. Allarie noted that EQT’s broad portfolio of biotech companies provides streamlined access to potential customers for the underserved reentry market.

Exolaunch joins other commercial entities seeking Starfall capacity. Last month, Redwire’s SpaceMD subsidiary announced plans to fly 32 variants of its PIL-BOXes on a 2028 mission to study drug development. Additionally, Space Cargo Unlimited booked the full 1,000 kg of space on a 2028 Starfall flight for its in-space manufacturing facility, having already sold out one-third of that mission.

The Bottom Line

Exolaunch’s agreement highlights growing commercial demand for Starship-based Earth-return missions, with multiple integrators competing to secure payload slots for biotech and manufacturing applications ahead of the NET 2029 launch window.